292 related articles for article (PubMed ID: 24323134)
1. Lipid management in chronic kidney disease: synopsis of the Kidney Disease: Improving Global Outcomes 2013 clinical practice guideline.
Tonelli M; Wanner C;
Ann Intern Med; 2014 Feb; 160(3):182. PubMed ID: 24323134
[TBL] [Abstract][Full Text] [Related]
2. Evaluation and management of chronic kidney disease: synopsis of the kidney disease: improving global outcomes 2012 clinical practice guideline.
Stevens PE; Levin A;
Ann Intern Med; 2013 Jun; 158(11):825-30. PubMed ID: 23732715
[TBL] [Abstract][Full Text] [Related]
3. KDOQI US commentary on the 2013 KDIGO Clinical Practice Guideline for Lipid Management in CKD.
Sarnak MJ; Bloom R; Muntner P; Rahman M; Saland JM; Wilson PW; Fried L
Am J Kidney Dis; 2015 Mar; 65(3):354-66. PubMed ID: 25465166
[TBL] [Abstract][Full Text] [Related]
4. KDIGO Clinical Practice Guideline for Lipid Management in CKD: summary of recommendation statements and clinical approach to the patient.
Wanner C; Tonelli M;
Kidney Int; 2014 Jun; 85(6):1303-9. PubMed ID: 24552851
[TBL] [Abstract][Full Text] [Related]
5. Prevention, Diagnosis, Evaluation, and Treatment of Hepatitis C Virus Infection in Chronic Kidney Disease: Synopsis of the Kidney Disease: Improving Global Outcomes 2018 Clinical Practice Guideline.
Gordon CE; Berenguer MC; Doss W; Fabrizi F; Izopet J; Jha V; Kamar N; Kasiske BL; Lai CL; Morales JM; Patel PR; Pol S; Silva MO; Balk EM; Earley A; Di M; Cheung M; Jadoul M; Martin P
Ann Intern Med; 2019 Oct; 171(7):496-504. PubMed ID: 31546256
[TBL] [Abstract][Full Text] [Related]
6. [Clinical practice guidelines for the management of dyslipidemia in chronic kidney disease].
Shoji T
Nihon Jinzo Gakkai Shi; 2013; 55(7):1267-75. PubMed ID: 24288962
[No Abstract] [Full Text] [Related]
7. KDOQI US commentary on the 2012 KDIGO clinical practice guideline for the evaluation and management of CKD.
Inker LA; Astor BC; Fox CH; Isakova T; Lash JP; Peralta CA; Kurella Tamura M; Feldman HI
Am J Kidney Dis; 2014 May; 63(5):713-35. PubMed ID: 24647050
[TBL] [Abstract][Full Text] [Related]
8. Lipid management in patients with chronic kidney disease.
Ferro CJ; Mark PB; Kanbay M; Sarafidis P; Heine GH; Rossignol P; Massy ZA; Mallamaci F; Valdivielso JM; Malyszko J; Verhaar MC; Ekart R; Vanholder R; London G; Ortiz A; Zoccali C
Nat Rev Nephrol; 2018 Dec; 14(12):727-749. PubMed ID: 30361677
[TBL] [Abstract][Full Text] [Related]
9. Using pharmacists to improve risk stratification and management of stage 3A chronic kidney disease: a feasibility study.
Chang AR; Evans M; Yule C; Bohn L; Young A; Lewis M; Graboski E; Gerdy B; Ehmann W; Brady J; Lawrence L; Antunes N; Green J; Snyder S; Kirchner HL; Grams M; Perkins R
BMC Nephrol; 2016 Nov; 17(1):168. PubMed ID: 27825313
[TBL] [Abstract][Full Text] [Related]
10. Is lipid management effective for all stages of CKD?
Ku E; Campese V
Blood Purif; 2013; 35(1-3):26-30. PubMed ID: 23343543
[TBL] [Abstract][Full Text] [Related]
11. Diabetes Management in Chronic Kidney Disease: Synopsis of the 2020 KDIGO Clinical Practice Guideline.
Navaneethan SD; Zoungas S; Caramori ML; Chan JCN; Heerspink HJL; Hurst C; Liew A; Michos ED; Olowu WA; Sadusky T; Tandon N; Tuttle KR; Wanner C; Wilkens KG; Lytvyn L; Craig JC; Tunnicliffe DJ; Howell M; Tonelli M; Cheung M; Earley A; Rossing P; de Boer IH; Khunti K
Ann Intern Med; 2021 Mar; 174(3):385-394. PubMed ID: 33166222
[TBL] [Abstract][Full Text] [Related]
12. Canadian Society of Nephrology commentary on the 2012 KDIGO clinical practice guideline for the management of blood pressure in CKD.
Ruzicka M; Quinn RR; McFarlane P; Hemmelgarn B; Ramesh Prasad GV; Feber J; Nesrallah G; MacKinnon M; Tangri N; McCormick B; Tobe S; Blydt-Hansen TD; Hiremath S
Am J Kidney Dis; 2014 Jun; 63(6):869-87. PubMed ID: 24725980
[TBL] [Abstract][Full Text] [Related]
13. Controversies Regarding Lipid Management and Statin Use for Cardiovascular Risk Reduction in Patients With CKD.
Markossian T; Burge N; Ling B; Schneider J; Pacold I; Bansal V; Leehey D; Stroupe K; Chang A; Kramer H
Am J Kidney Dis; 2016 Jun; 67(6):965-77. PubMed ID: 26943983
[TBL] [Abstract][Full Text] [Related]
14. Ezetimibe as a potential treatment for dyslipidemia associated with chronic renal failure and renal transplant.
Ahmed MH; Khalil AA
Saudi J Kidney Dis Transpl; 2010 Nov; 21(6):1021-9. PubMed ID: 21060168
[TBL] [Abstract][Full Text] [Related]
15. Focused atorvastatin therapy in managed-care patients with coronary heart disease and CKD.
Koren MJ; Davidson MH; Wilson DJ; Fayyad RS; Zuckerman A; Reed DP;
Am J Kidney Dis; 2009 May; 53(5):741-50. PubMed ID: 19216014
[TBL] [Abstract][Full Text] [Related]
16. [Dyslipidemia and the risk of kidney disease].
Ligabue G; Cavazzini F; Albertazzi A
G Ital Nefrol; 2007; 24 Suppl 38():8-12. PubMed ID: 17922441
[TBL] [Abstract][Full Text] [Related]
17. Management of Blood Pressure in Patients With Chronic Kidney Disease Not Receiving Dialysis: Synopsis of the 2021 KDIGO Clinical Practice Guideline.
Tomson CRV; Cheung AK; Mann JFE; Chang TI; Cushman WC; Furth SL; Hou FF; Knoll GA; Muntner P; Pecoits-Filho R; Tobe SW; Lytvyn L; Craig JC; Tunnicliffe DJ; Howell M; Tonelli M; Cheung M; Earley A; Ix JH; Sarnak MJ
Ann Intern Med; 2021 Sep; 174(9):1270-1281. PubMed ID: 34152826
[TBL] [Abstract][Full Text] [Related]
18. Assessment of nonimmunologic factors in kidney transplant recipients according to Kidney Disease Improving Global Outcomes.
Dounousi E; Mitsis M; Spanos G; Pappas C; Koutlas V; Tzalavra I; Xarisis C; Glantzounis G; Fatouros M; Siamopoulos KC
Transplant Proc; 2012 Nov; 44(9):2709-11. PubMed ID: 23146500
[TBL] [Abstract][Full Text] [Related]
19. [Effect of statins on renal function].
Kasahara M
Nihon Jinzo Gakkai Shi; 2013; 55(7):1295-300. PubMed ID: 24288966
[No Abstract] [Full Text] [Related]
20. [Statins: what is their place in the treatment of chronic kidney insufficiency?].
Ponte B; Bourquin V; Stoermann-Chopard C
Rev Med Suisse; 2009 Feb; 5(192):463-4, 466-8. PubMed ID: 19317313
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
